Fig. 3From: Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patientsMechanistic network of inhibited TGF-β1. Generated on the basis of relationships to identified transcriptional changes in responders at the time of progression. The three closest related regulators in the network are SMAD3, HIF1A and PPARG and the two most related downstream molecules are CDKN1A and SERPINE1Back to article page